HMGCR Protein — HMG-CoA Reductase

Overview

Pathway Diagram

flowchart TD
    HMGCR["HMGCR<br/>HMG-CoA Reductase<br/>Rate-limiting enzyme"]
    
    Cholesterol["Cholesterol<br/>Biosynthesis<br/>Pathway"]
    Statins["Statin Therapy<br/>HMGCR Inhibition"]
    
    APP["APP<br/>Amyloid Precursor<br/>Protein"]
    PSEN1["PSEN1<br/>Presenilin-1<br/>gamma-secretase component"]
    MAPT["MAPT<br/>Tau Protein<br/>Microtubule binding"]
    
    Inflammation["Neuroinflammation<br/>IL1B-mediated<br/>responses"]
    IL1B["IL1B<br/>Interleukin-1beta<br/>Pro-inflammatory"]
    
    Apoptosis["Apoptosis<br/>Pathway<br/>Cell death"]
    PARP1["PARP1<br/>DNA repair<br/>enzyme"]
    DAPK1["DAPK1<br/>Death-associated<br/>protein kinase"]
    
    Alzheimer["Alzheimer's<br/>Disease"]
    ALS["ALS<br/>Motor neuron<br/>degeneration"]
    Dementia["Dementia<br/>Cognitive decline"]
    Depression["Depression<br/>Mood disorder"]
    
    HMGCR -->|"regulates"| Cholesterol
    HMGCR -->|"interacts_with"| APP
    HMGCR -->|"interacts_with"| PSEN1
    HMGCR -->|"interacts_with"| MAPT
    HMGCR -->|"inhibits"| Inflammation
    HMGCR -->|"interacts_with"| IL1B
    HMGCR -->|"modulates"| Apoptosis
    HMGCR -->|"interacts_with"| PARP1
    HMGCR -->|"interacts_with"| DAPK1
    
    Statins -->|"inhibits"| HMGCR
    
    APP -->|"contributes_to"| Alzheimer
    PSEN1 -->|"contributes_to"| Alzheimer
    MAPT -->|"contributes_to"| Alzheimer
    
    HMGCR -->|"associated_with"| Alzheimer
    HMGCR -->|"associated_with"| ALS
    HMGCR -->|"therapeutic_target"| Dementia
    HMGCR -->|"associated_with"| Depression
    
    Apoptosis -->|"leads_to"| ALS
    Inflammation -->|"contributes_to"| Alzheimer
    
    style HMGCR fill:#006494
    style Statins fill:#1b5e20
    style Cholesterol fill:#4a1a6b
    style Inflammation fill:#ef5350
    style Apoptosis fill:#ef5350
    style Alzheimer fill:#5d4400
    style ALS fill:#5d4400
    style Dementia fill:#5d4400
    style Depression fill:#5d4400
    style APP fill:#4a1a6b
    style PSEN1 fill:#4a1a6b
    style MAPT fill:#4a1a6b

Hmgcr Protein — Hmg Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Hmgcr Protein — Hmg Coa Reductase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. ^{1**Carter CJ.** (2007). "Alzheimer's disease: APP, gamma-secretase, APOE, LDLR, and cholesterol: a pathological triad?" *Journal of Neurochemistry*2007 · Carter CJ. · DOI 10.1111/j.1471-4159.2007.04586.xOpen reference}

HMG-CoA reductase (HMGCR) is the rate-limiting enzyme in the mevalonate pathway for cholesterol biosynthesis. It catalyzes the conversion of HMG-CoA to mevalonate. While extensively studied for its role in cardiovascular disease and as the target of statins, HMGCR also plays important roles in brain cholesterol metabolism. In neurons, cholesterol is essential for synaptic vesicle formation, neurotransmitter release, and membrane rafts that host signaling proteins.

Protein Overview

Structure

CYP46A1 Structure

• Contains the conserved P450 heme-binding domain

• N-terminal transmembrane anchor for ER localization

• Substrate access channel for cholesterol

HMGCR Structure

• N-terminal transmembrane domain (8 transmembrane helices)

• C-terminal catalytic domain facing the cytosol

• Sterol-sensing domain for regulation

SREBF2 Structure

• N-terminal transcription activation domain

• Basic-helix-loop-helix (bHLH) DNA-binding domain

• Two transmembrane helices anchor to ER

• Sterol-sensing domain

Normal Function

Cholesterol Metabolism

HMGCR is central to maintaining cholesterol homeostasis:

CYP46A1:

• Converts cholesterol to 24(S)-hydroxycholesterol

• Enables cholesterol efflux across BBB

• Regulated by LXR nuclear receptors

HMGCR:

• Rate-limiting step in cholesterol synthesis

• Feedback inhibition by cholesterol

• Target of statin medications

SREBP-2:

• Master regulator of cholesterol genes

• Activates LDLR, HMGCR, and other genes

• Regulated by cellular cholesterol levels

Role in Alzheimer’s Disease

Cholesterol-Aβ Relationship

Elevated brain cholesterol is associated with increased Aβ production:

• Cholesterol-rich lipid rafts host APP processing enzymes

• Altered membrane fluidity affects secretase activity

• Cholesterol depletion reduces Aβ generation

Therapeutic Implications

See Also

• Proteins/Hmgcr-Protein — This page

Overview

Hmgcr Protein — Hmg Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Hmgcr Protein — Hmg Coa Reductase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data

Cross-References

• CYP46A1 Gene - Encoding gene

• HMGCR Gene - Encoding gene

• SREBF2 Gene - Encoding gene

• Cholesterol Metabolism in AD

• APOE Gene - Apolipoprotein E